References
Orion Corporation. Orion Group Interim Report 1–6/2003. Media Release: 6 Aug 2003. Available from URL: http://www.orion.fi
Novartis Pharmaceuticals Corporation. FDA Approves Stalevo™ for Treatment of Parkinson’s Disease. Media Release: 13 Jun 2003. Available from URL: http://www.novartis.com
Myllylä V, Kaakkola S, Miettinen TE. et al. New triple combination of levodopa/carbidopa/entacapone is a preferred treatment in patients with Parkinson’s disease. Neurology 60 (Suppl. 1): 289, 11 Mar 2003
Rights and permissions
About this article
Cite this article
Entacapone/Levodopa/Carbidopa Combination Tablet. Drugs R&D 4, 310–311 (2003). https://doi.org/10.2165/00126839-200304050-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-200304050-00006